PH24118A - Insulin formulations - Google Patents

Insulin formulations

Info

Publication number
PH24118A
PH24118A PH32375A PH32375A PH24118A PH 24118 A PH24118 A PH 24118A PH 32375 A PH32375 A PH 32375A PH 32375 A PH32375 A PH 32375A PH 24118 A PH24118 A PH 24118A
Authority
PH
Philippines
Prior art keywords
plunger pipe
plate
damper
sealing plate
pipe
Prior art date
Application number
PH32375A
Inventor
Ulrich Grau
Gerhard Ross
Dietrich Hiller
Horst Paul Neubauer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19843443877 external-priority patent/DE3443877A1/en
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of PH24118A publication Critical patent/PH24118A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Luminescent Compositions (AREA)
  • Steroid Compounds (AREA)
  • Prostheses (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • External Artificial Organs (AREA)

Abstract

1. Pulsation damper (10) for elastically disposed objects (26), including a damper housing which is at least partially filled with 3 viscose damping medium (12) and which is open at the top relative to its installation position ; a hollow plunger pipe (17) which is open at the bottom relative to its installation position and continuously conically formed and which can be moved up and down into the damper medium (12) ; a top plate (16), linked with the plunger pipe (17), for receiving the object (26), in which respect the plunger pipe (17) is connected with the top plate (16) by its smaller diameter (28), and its larger diameter (29) is emersed into the damper medium (12), characterised in that the interior of the plunger pipe (17) is divided into two chambers by a sealing plate (22) ; that a buffer plate (24) including passages (33) is disposed in the larger diameter (29) at the bottom of the plunger pipe (17) which plate carries a plurality of interior pipes (21) which extend into the plunger pipe (17), the upper ends of the interior pipes (21) being at a distance (35) from the sealing plate (22), and the plunger pipe (17) has a plurality of peripheral bores (19) in the casing surface below the sealing plate (22).
PH32375A 1984-06-09 1985-06-07 Insulin formulations PH24118A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE3421615 1984-06-09
DE3421613 1984-06-09
DE19843443877 DE3443877A1 (en) 1984-06-09 1984-12-01 Insulin preparations, process for their preparation, and their use

Publications (1)

Publication Number Publication Date
PH24118A true PH24118A (en) 1990-03-05

Family

ID=27192050

Family Applications (1)

Application Number Title Priority Date Filing Date
PH32375A PH24118A (en) 1984-06-09 1985-06-07 Insulin formulations

Country Status (16)

Country Link
EP (1) EP0166971B1 (en)
AT (1) ATE50502T1 (en)
AU (1) AU575951B2 (en)
CA (1) CA1258427A (en)
DE (1) DE3576120D1 (en)
DK (1) DK162255C (en)
ES (1) ES8605679A1 (en)
FI (1) FI80596C (en)
GR (1) GR851393B (en)
HU (1) HU200102B (en)
IE (1) IE57998B1 (en)
IL (1) IL75448A (en)
NO (1) NO164277C (en)
NZ (1) NZ212338A (en)
PH (1) PH24118A (en)
PT (1) PT80620B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO179479C (en) * 1988-03-11 1996-10-16 Teikoku Seiyaku Kk Process for the preparation of an intravaginal pharmaceutical preparation
DE10114178A1 (en) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinc-free and low-zinc insulin preparations with improved stability
DE10227232A1 (en) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Sour insulin preparations with improved stability
PT3228320T (en) 2008-10-17 2020-03-26 Sanofi Aventis Deutschland Combination of an insulin and a glp-1 agonist
US10029011B2 (en) 2009-11-13 2018-07-24 Sanofi-Aventis Deutschland Gmbh Pharmaceutical composition comprising a GLP-1 agonist, an insulin and methionine
PT2498801T (en) 2009-11-13 2018-05-02 Sanofi Aventis Deutschland Pharmaceutical composition comprising despro36exendin-4(1-39)-lys6-nh2 and methionine
SG187904A1 (en) 2010-08-30 2013-04-30 Sanofi Aventis Deutschland Use of ave0010 for the manufacture of a medicament for the treatment of diabetes mellitus type 2
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
AR087744A1 (en) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF A NEURODEGENERATIVE DISEASE
JP6457484B2 (en) 2013-04-03 2019-01-23 サノフイＳａｎｏｆｉ Treatment of diabetes with long-acting insulin preparations
NZ733670A (en) 2014-12-12 2021-12-24 Sanofi Aventis Deutschland Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (en) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 Treatment type 2 diabetes mellitus patients
TW201705975A (en) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 Treatment of type 2 diabetes mellitus patients

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2474729A (en) * 1945-01-03 1949-06-28 Rhone Poulenc Sa Insulin preparations
US2574889A (en) * 1947-10-06 1951-11-13 Leo Ab Methylated gelatin-insulin preparation
SU1011126A1 (en) * 1981-07-14 1983-04-15 Всесоюзный научно-исследовательский и испытательный институт медицинской техники Method of treating diabetes mellitus
ZW17382A1 (en) * 1981-08-27 1982-11-17 Lilly Co Eli Human proinsulin pharmaceutical formulations
FI78616C (en) * 1982-02-05 1989-09-11 Novo Industri As Process for preparing an infused stabilized insulin solution having an elevated zinc content
AU4292585A (en) * 1984-04-30 1985-11-28 Trustees Of Columbia University In The City Of New York, The Topical treatment of diabetes with insulin and penetrant enhancer applied to the skin and covered by a patch

Also Published As

Publication number Publication date
EP0166971A1 (en) 1986-01-08
HUT37893A (en) 1986-03-28
IE851431L (en) 1985-12-09
PT80620B (en) 1987-10-20
GR851393B (en) 1985-11-25
NZ212338A (en) 1989-02-24
FI852273A0 (en) 1985-06-06
AU4342485A (en) 1985-12-12
IE57998B1 (en) 1993-06-02
IL75448A0 (en) 1985-10-31
HU200102B (en) 1990-04-28
FI80596B (en) 1990-03-30
NO164277C (en) 1990-09-19
NO852314L (en) 1985-12-10
NO164277B (en) 1990-06-11
DK254585D0 (en) 1985-06-06
ATE50502T1 (en) 1990-03-15
DK162255C (en) 1992-03-16
PT80620A (en) 1985-07-01
DE3576120D1 (en) 1990-04-05
FI852273L (en) 1985-12-10
ES543972A0 (en) 1986-01-16
IL75448A (en) 1989-07-31
CA1258427A (en) 1989-08-15
EP0166971B1 (en) 1990-02-28
AU575951B2 (en) 1988-08-11
ES8605679A1 (en) 1986-01-16
DK254585A (en) 1985-12-10
FI80596C (en) 1990-07-10
DK162255B (en) 1991-10-07

Similar Documents

Publication Publication Date Title
IE851431L (en) Insulin formulations
FR2663102B1 (en) ELASTIC SUPPORT FILLED WITH A FLUID AND COMPRISING A MATTE PART FOR SEALING A CHAMBER CONTAINING A FLUID AND METHOD FOR MANUFACTURING SUCH A SUPPORT.
JPS646543A (en) Vibration isolating device
FI871937A (en) ANORDERING FOR ANAEROBIC RENGTHENING AV AVFALLSVATTEN.
PT823288E (en) MINIATURE PUMP STATION MOUNTING SYSTEM IN A SMALL CAPACITY RESERVOIR
DE3866619D1 (en) BIOGAS REACTOR.
DE69010781D1 (en) Device for chest drainage.
JPS57173663A (en) Connecting piece with sealed ring
DE59906300D1 (en) Fluid shock absorber
JPS57127141A (en) Multi-direction vibration-proof device
ATE67015T1 (en) VIBRATION DAMPERS FOR MACHINE BEARINGS.
GR3006386T3 (en)
DE3564858D1 (en) Arrangement with a sealed evacuated hollow body
ATE21921T1 (en) HORIZONTAL CHAMBER COKING FURNACE.
ES257901U (en) Tomamuestras head for blood sedimentation speed meter. (Machine-translation by Google Translate, not legally binding)
JPS5576238A (en) Automobile damper
UA39943C2 (en) ENERGY COMPENSATOR
ES285175U (en) Solar phototermica plate (Machine-translation by Google Translate, not legally binding)
SE8504611L (en) WATER
IT1235157B (en) Suspension in a rubber sleeve with hydraulic dampening, in particular for machine parts
JPS6254885U (en)